State AZ
Clinical Trials in Arizona
Recruiting clinical trials with at least one study location in Arizona. Data updated daily from ClinicalTrials.gov.
Top Conditions in Arizona
NCT07116876 N/A
Recruiting
Matrion Decellularized Placental Membrane Versus Conventional Wound Management i...
Condition
Diabetic Foot Ulcer (DFU)
Enrollment
120 pts
Location
United States
Sponsor
LifeNet Health
NCT06385886 N/A
Recruiting
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for S...
Condition
Sickle Cell Disease
Enrollment
500 pts
Location
United States
Sponsor
RTI International
NCT07219966 Phase 3
Recruiting
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disor...
Condition
Alcohol Use Disorder
Enrollment
1,100 pts
Location
United States, Belgium, China
Sponsor
Eli Lilly and Company
NCT05977751 N/A
Recruiting
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
Condition
Contraception
Enrollment
573 pts
Location
United States
Sponsor
Femasys Inc.
NCT07145229 Phase 2
Recruiting
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Condition
Acute Gouty Arthritis
Enrollment
380 pts
Location
United States, Australia, China
Sponsor
Atom Therapeutics Co., Ltd
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT06990269 Phase 2
Recruiting
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Condition
Geographic Atrophy Secondary to Age-related Macular Degeneration
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
ADARx Pharmaceuticals, Inc.
NCT03016819 Phase 3
Recruiting
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarco...
Condition
Alveolar Soft Part Sarcoma
Enrollment
325 pts
Location
United States, China, Italy
Sponsor
Advenchen Laboratories, LLC
NCT04951622 Phase 3
Recruiting
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Condition
Myasthenia Gravis
Enrollment
199 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
NCT06071845 N/A
Recruiting
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of E...
Condition
Barrett Esophagus
Enrollment
400 pts
Location
United States
Sponsor
Mayo Clinic
NCT06972459 Phase 3
Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight a...
Condition
Obesity
Enrollment
600 pts
Location
United States, Argentina, China
Sponsor
Eli Lilly and Company
NCT05546580 Phase 1
Recruiting
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyr...
Condition
Acute Myeloid Leukemia, in Relapse
Enrollment
50 pts
Location
United States
Sponsor
Oryzon Genomics S.A.
NCT06925737 Phase 3
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Pros...
Condition
Prostate Cancer
Enrollment
1,440 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
NCT06499857 Phase 3
Recruiting
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrilla...
Condition
Overweight or Obesity
Enrollment
200 pts
Location
United States
Sponsor
University of Chicago
NCT06384261 Phase 2
Recruiting
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and ...
Condition
Leukemia, Myeloid, Acute
Enrollment
120 pts
Location
United States, Canada, Germany
Sponsor
OncoVerity, Inc.
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT05894239 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Ph...
Condition
Metastatic Breast Cancer
Enrollment
230 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT07207369 Phase 3
Recruiting
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Ad...
Condition
Acne Scars
Enrollment
395 pts
Location
United States
Sponsor
AbbVie
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
NCT05101551 Phase 1
Recruiting
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML ...
Condition
Acute Myeloid Leukemia
Enrollment
34 pts
Location
United States
Sponsor
Norman J. Lacayo
NCT06066502 Phase 3
Recruiting
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
Condition
Acute Respiratory Distress Syndrome
Enrollment
1,100 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
NCT06014502 Phase 1
Recruiting
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Adv...
Condition
Solid Tumor
Enrollment
105 pts
Location
United States
Sponsor
ImmunoGenesis